The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

Image of a person in a white shirt on a black background holding and activating a white nasal spray bottle to make a plume.

Clearing the Way for Nasal Vaccines

An oldfield mouse mother with its babies.

On a Wild Mouse Chase to Understand Parenting, Love, and Fear

A microscopy image showing white rounded cells with pink borders.

A Protein That Converts Fat-Storing Cells into Calorie-Burning Cells 

Cluster of blue cells encasing green tube structures. 

The Era of Organoids: Disease Modeling, Developmental Research, and Drug Response Prediction 

A person sitting in a gym with a protein shake bottle and kettlebell placed beside them.

Exerkines: Molecular Messengers That Mediate Exercise Effects 

Mozambique cobra snake<strong >&nbsp;</strong>

Artificial Blood Vessels Help Scientists Study Deadly Snakebites

Illustration of a mosquito ingesting blood with bright green circles representing parasites entering its abdomen with the blood. A depiction of a white blood clot with red blood cells makes up the background.

Targeting Mosquito Spit Could Stop Parasites in Their Tracks

An illustration of an orange tau fibril in front of a blue background.

Uncovering the Unexpected: Developing a Novel Anti-Tau Therapy

Gram-negative, rod-shaped bacteria expressing pili.

Building Bacterial Drug Factories

A man holds his knee and grimaces in pain while sitting in front of a bridge.

A Nanoparticle Approach to Treat Torn Tendons

Graphic depicting a tumor being targeted by a drug

Great Anticancer Potential Comes in a Small Package 

A digitized human brain in blue sits on top of a computer microchip

Artificial Intelligence in Biology: From Neural Networks to AlphaFold

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies